General information

Announcements(0)

Greetings from the Chair

Overview

Web abstract

Best Student Presentation Award

Selected programs of presentations in English

Registration

Registration (Non-presenters under 4th year underg

Information for Participants

Information for Presenters and Chairs

Banquet

Luncheon Seminar & Career Design Seminar

General information 2

Abstract Submission (Oral/Poster Presentation) for

Abstract Submission (Oral/Poster Presentation)

Timetable

Fri. Mar 29, 2024

Sat. Mar 30, 2024

Sun. Mar 31, 2024

Program

Sessions

Search presentations

20230323085903895_en.png

app_icon.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Enter the password to view the abstracts.<br><br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Profile management

Announcements

Bookmark

Download PDF for print

Targeting epigenome alterations in cancer therapy - current status and perspective -

Therapeutic options for cancer become constricted as the cancer stage progresses. First-line anticancer regimens have recently diversified the available options for cancer therapeutics owing to the increased number of molecular target anticancer drugs, as well as the clinical application of immunotherapy using immune checkpoint inhibitors. In addition, the standardization of tailor-made medicine using genome information is advancing to further improve the selection and effectiveness of diversified anticancer drugs. Furthermore, the epigenome will become an important consideration in cancer genomic research and drug development in the future. Further developments in cancer immunology and genomics are essential for improving the quality of life of cancer patients and increasing the effectiveness of therapy based on an understanding of cancer pathophysiology. This symposium will feature leading experts in the fields of cancer immunology and genomic medicine to discuss the latest strategies in cancer therapy.

Latest strategies for cancer management based on cancer immunology and cancer genomic medicine

The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)

Presentation Information

[S15-4]Targeting epigenome alterations in cancer therapy - current status and perspective -

Password required to view